In the early 1990s, the first clinical trial of gene therapy for genetic diseases was started using retroviral-mediated transfer of the adenosine deaminase gene into T cells to cure the severe combined immunodeficiency caused by the lack of adenosine-deaminase [116, 117]. Here, ADA is linked to immunodeficiency disease.